Dataset Information


Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies.

ABSTRACT: The accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG-PET/CT) can be influenced by the increased glycolytic activity of inflammatory lesions. Here, using clinical data obtained from gynecological cancer patients, tumor samples and animal models, we investigate the impact of pretreatment tumor-related leukocytosis (TRL) on the diagnostic performance of 18F-FDG-PET/CT in detecting pelvic and paraaortic lymph node metastasis. We demonstrate that pretreatment TRL misleads 18F-FDG-PET/CT during lymph node staging in gynecological malignancies. In the mechanistic investigations, we show that the false-positive 18F-FDG-PET/CT result for detecting nodal metastasis can be reproduced in animal models of TRL-positive cancer bearing G-CSF expressing cervical cancer cells. We also show that increased 18F-FDG uptake in non-metastatic nodes can be explained by the MDSC-mediated premetastatic niche formation in which proinflammatory factors, such as S100A8 or S100A9, are abundantly expressed. Together, our results suggest that the MDSC-mediated premetastatic niche created in the lymph node of TRL-positive patients misleads 18F-FDG-PET/CT for detecting nodal metastasis.


PROVIDER: S-EPMC7069975 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7600235 | BioStudies
2020-01-01 | S-EPMC7082024 | BioStudies
2020-01-01 | S-EPMC7160067 | BioStudies
2019-01-01 | S-EPMC6928175 | BioStudies
2018-01-01 | S-EPMC6095513 | BioStudies
2015-01-01 | S-EPMC4289066 | BioStudies
2020-01-01 | S-EPMC7488230 | BioStudies
2018-01-01 | S-EPMC5807531 | BioStudies
2019-01-01 | S-EPMC6713799 | BioStudies
2020-01-01 | S-EPMC7063714 | BioStudies